Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Neuronetics (STIM) Shares Issued (2017 - 2025)

Neuronetics has reported Shares Issued over the past 8 years, most recently at $7.8 million for Q4 2025.

  • Quarterly Shares Issued rose 209.01% to $7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.8 million through Dec 2025, up 1209.61% year-over-year, with the annual reading at $7.8 million for FY2025, 209.4% up from the prior year.
  • Shares Issued was $7.8 million for Q4 2025 at Neuronetics, down from $8.3 million in the prior quarter.
  • Over five years, Shares Issued peaked at $81.0 million in Q1 2021 and troughed at -$78.7 million in Q2 2021.
  • The 4-year median for Shares Issued is $1.4 million (2022), against an average of $3.5 million.
  • The largest YoY upside for Shares Issued was 106442.11% in 2021 against a maximum downside of 163993.75% in 2021.
  • A 4-year view of Shares Issued shows it stood at -$78.5 million in 2021, then surged by 100.31% to $246000.0 in 2022, then skyrocketed by 924.39% to $2.5 million in 2024, then soared by 209.01% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Shares Issued are $7.8 million (Q4 2025), $8.3 million (Q3 2025), and $20.7 million (Q2 2025).